I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophi — NSF Award to Cornell University (NY,
The broader impact/commercial potential of this I-Corps project is the development of a blood-based biomarker for the detection and monitoring of Amyotrophic Lateral Sclerosis (ALS). The advent of new drugs for treating ALS has resulted in increased demand for ALS detection. Currently, diagnosis times may take up to 2
| Award title | I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophi |
|---|---|
| Award ID | 2317745 |
| Awardee | Cornell University |
| City | ITHACA |
| State | NY |
| Amount obligated | $50,000 |
| Principal investigator | Madhur Srivastava |
| Program | I-Corps |
| Start date | 04/01/2023 |
| Abstract | The broader impact/commercial potential of this I-Corps project is the development of a blood-based biomarker for the detection and monitoring of Amyotrophic Lateral Sclerosis (ALS). The advent of new drugs for treating ALS has resulted in increased demand for ALS detection. Currently, diagnosis times may take up to 2 years and cost about $40K per diagnostic test. The proposed technology may be used to develop a non-invasive, point-of-care diagnostic for ALS, that may be priced at $200 per test, |
| Source | NSF Awards |
$799/mo
Try NSFGrants →